SG10201403512TA - Methods of treating a pulmonary bacterial infection using fluoro-quinolones - Google Patents

Methods of treating a pulmonary bacterial infection using fluoro-quinolones

Info

Publication number: SG10201403512TA
Authority: SG; Singapore
Prior art keywords: quinolones; fluoro; treating; methods; bacterial infection
Prior art date: 2009-04-24

Application number

SG10201403512TA

Original Assignee

Mpex Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-04-24

Filing date

2010-04-22

Publication date

2014-08-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43011488&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG10201403512T(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-04-22 Application filed by Mpex Pharmaceuticals Inc filed Critical Mpex Pharmaceuticals Inc

2014-08-28 Publication of SG10201403512TA publication Critical patent/SG10201403512TA/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Otolaryngology (AREA)
Oncology (AREA)
Dispersion Chemistry (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

SG10201403512TA 2009-04-24 2010-04-22 Methods of treating a pulmonary bacterial infection using fluoro-quinolones SG10201403512TA (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US17262509P	2009-04-24	2009-04-24

Publications (1)

Publication Number	Publication Date
SG10201403512TA true SG10201403512TA (en)	2014-08-28

Family

ID=43011488

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
SG10201403512TA SG10201403512TA (en)	2009-04-24	2010-04-22	Methods of treating a pulmonary bacterial infection using fluoro-quinolones
SG10201811494SA SG10201811494SA (en)	2009-04-24	2010-04-22	Methods of treating a pulmonary bacterial infection using fluoroquinolones
SG2011076932A SG175288A1 (en)	2009-04-24	2010-04-22	Methods of treating a pulmonary bacterial infection using fluoro-quinolones

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
SG10201811494SA SG10201811494SA (en)	2009-04-24	2010-04-22	Methods of treating a pulmonary bacterial infection using fluoroquinolones
SG2011076932A SG175288A1 (en)	2009-04-24	2010-04-22	Methods of treating a pulmonary bacterial infection using fluoro-quinolones

Country Status (28)

Country	Link
US (2)	US20120035166A1 (en)
EP (1)	EP2421539B1 (en)
JP (2)	JP6179844B2 (en)
KR (1)	KR20120034626A (en)
CN (2)	CN107050032A (en)
AU (1)	AU2010238765B2 (en)
BR (1)	BRPI1006626B8 (en)
CA (1)	CA2759874C (en)
CL (1)	CL2011002649A1 (en)
CO (1)	CO6450642A2 (en)
CY (1)	CY1122525T1 (en)
DK (1)	DK2421539T3 (en)
ES (1)	ES2755754T3 (en)
HR (1)	HRP20191951T1 (en)
HU (1)	HUE046595T2 (en)
IL (1)	IL215777A (en)
LT (1)	LT2421539T (en)
MX (1)	MX339077B (en)
MY (1)	MY178871A (en)
NZ (1)	NZ596245A (en)
PL (1)	PL2421539T3 (en)
PT (1)	PT2421539T (en)
RU (1)	RU2535056C2 (en)
SG (3)	SG10201403512TA (en)
SI (1)	SI2421539T1 (en)
SM (1)	SMT201900645T1 (en)
WO (1)	WO2010124141A1 (en)
ZA (1)	ZA201107903B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8524735B2 (en) *	2005-05-18	2013-09-03	Mpex Pharmaceuticals, Inc.	Aerosolized fluoroquinolones and uses thereof
CA2739897C (en)	2008-10-07	2017-10-03	Mpex Pharmaceuticals, Inc.	Aerosol fluoroquinolone formulations for improved pharmacokinetics
US8629139B2 (en)	2008-10-07	2014-01-14	Mpex Pharmaceuticals, Inc.	Topical use of Levofloxacin for reducing lung inflammation
EP2473170B1 (en)	2009-09-04	2019-06-19	Horizon Orphan LLC	Use of aerosolized levofloxacin for treating cystic fibrosis
US9572774B2 (en)	2011-05-19	2017-02-21	Savara Inc.	Dry powder vancomycin compositions and associated methods
CA2905975A1 (en) *	2013-03-14	2014-09-25	Cempra Pharmaceuticals, Inc.	Methods for treating respiratory diseases and formulations therefor
JP6966835B2 (en) *	2016-02-05	2021-11-17	ホライズンオーファンリミテッドライアビリティカンパニー	Fluoroquinolone preparation for cystic fibrosis
CN108849939B (en) *	2018-07-31	2021-02-19	广东省农业科学院植物保护研究所	Application of levofloxacin hydrochloride in the preparation of pesticide formulations for the control of tobacco bacterial wilt

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2477982A1 (en) *	2002-03-05	2003-09-18	Transave, Inc.	Methods for entrapment of bioactive agent in a liposome or lipid complex
RU2255757C1 (en) *	2004-06-22	2005-07-10	Санкт-Петербургская Общественная Организация "Санкт-Петербургский Институт Биорегуляции И Геронтологии Сзо Рамн"	Peptide compound recovering function of respiratory organs
PL1901749T3 (en)	2005-05-18	2017-04-28	Horizon Orphan Llc	Aerosolized fluoroquinolones and uses thereof
US7838532B2 (en)	2005-05-18	2010-11-23	Mpex Pharmaceuticals, Inc.	Aerosolized fluoroquinolones and uses thereof
CA2724009C (en)	2008-05-15	2016-10-11	Novartis Ag	Pulmonary delivery of a fluoroquinolone
CA2739897C (en) *	2008-10-07	2017-10-03	Mpex Pharmaceuticals, Inc.	Aerosol fluoroquinolone formulations for improved pharmacokinetics

2010
- 2010-04-22 PT PT107678005T patent/PT2421539T/en unknown
- 2010-04-22 SG SG10201403512TA patent/SG10201403512TA/en unknown
- 2010-04-22 CN CN201610900988.6A patent/CN107050032A/en active Pending
- 2010-04-22 PL PL10767800T patent/PL2421539T3/en unknown
- 2010-04-22 MY MYPI2011005063A patent/MY178871A/en unknown
- 2010-04-22 SI SI201031951T patent/SI2421539T1/en unknown
- 2010-04-22 HR HRP20191951TT patent/HRP20191951T1/en unknown
- 2010-04-22 BR BRPI1006626A patent/BRPI1006626B8/en active IP Right Grant
- 2010-04-22 WO PCT/US2010/032128 patent/WO2010124141A1/en not_active Ceased
- 2010-04-22 RU RU2011145430/15A patent/RU2535056C2/en active
- 2010-04-22 DK DK10767800T patent/DK2421539T3/en active
- 2010-04-22 SM SM20190645T patent/SMT201900645T1/en unknown
- 2010-04-22 HU HUE10767800A patent/HUE046595T2/en unknown
- 2010-04-22 LT LT10767800T patent/LT2421539T/en unknown
- 2010-04-22 MX MX2011011190A patent/MX339077B/en active IP Right Grant
- 2010-04-22 EP EP10767800.5A patent/EP2421539B1/en active Active
- 2010-04-22 AU AU2010238765A patent/AU2010238765B2/en active Active
- 2010-04-22 SG SG10201811494SA patent/SG10201811494SA/en unknown
- 2010-04-22 JP JP2012507400A patent/JP6179844B2/en active Active
- 2010-04-22 NZ NZ596245A patent/NZ596245A/en unknown
- 2010-04-22 KR KR1020117027809A patent/KR20120034626A/en not_active Ceased
- 2010-04-22 SG SG2011076932A patent/SG175288A1/en unknown
- 2010-04-22 CA CA2759874A patent/CA2759874C/en active Active
- 2010-04-22 ES ES10767800T patent/ES2755754T3/en active Active
- 2010-04-22 CN CN2010800180220A patent/CN102427815A/en active Pending
2011
- 2011-10-21 US US13/278,706 patent/US20120035166A1/en not_active Abandoned
- 2011-10-23 IL IL215777A patent/IL215777A/en active IP Right Grant
- 2011-10-24 CL CL2011002649A patent/CL2011002649A1/en unknown
- 2011-10-29 ZA ZA2011/07903A patent/ZA201107903B/en unknown
- 2011-11-02 CO CO11148624A patent/CO6450642A2/en not_active Application Discontinuation
2015
- 2015-10-09 JP JP2015201285A patent/JP6228580B2/en not_active Expired - Fee Related
2019
- 2019-11-06 CY CY20191101155T patent/CY1122525T1/en unknown
2020
- 2020-02-20 US US16/796,525 patent/US20210015811A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CY1122525T1 (en)	2021-01-27
CO6450642A2 (en)	2012-05-31
KR20120034626A (en)	2012-04-12
EP2421539A1 (en)	2012-02-29
US20210015811A1 (en)	2021-01-21
CN107050032A (en)	2017-08-18
MX339077B (en)	2016-05-10
PT2421539T (en)	2019-11-22
CA2759874A1 (en)	2010-10-28
EP2421539B1 (en)	2019-10-23
LT2421539T (en)	2019-12-10
MY178871A (en)	2020-10-21
WO2010124141A1 (en)	2010-10-28
HRP20191951T1 (en)	2021-05-14
DK2421539T3 (en)	2019-11-18
EP2421539A4 (en)	2014-01-29
NZ596245A (en)	2013-11-29
CL2011002649A1 (en)	2012-06-22
RU2535056C2 (en)	2014-12-10
CA2759874C (en)	2016-11-08
SG10201811494SA (en)	2019-01-30
BRPI1006626A2 (en)	2020-07-28
AU2010238765A1 (en)	2011-11-10
SMT201900645T1 (en)	2020-01-14
PL2421539T3 (en)	2020-02-28
JP6228580B2 (en)	2017-11-08
ZA201107903B (en)	2013-01-30
AU2010238765B2 (en)	2014-12-18
IL215777A (en)	2017-09-28
JP2016053041A (en)	2016-04-14
ES2755754T3 (en)	2020-04-23
JP2012524811A (en)	2012-10-18
SG175288A1 (en)	2011-11-28
SI2421539T1 (en)	2019-12-31
US20120035166A1 (en)	2012-02-09
RU2011145430A (en)	2013-05-27
BRPI1006626B8 (en)	2021-05-25
BRPI1006626B1 (en)	2021-05-11
HUE046595T2 (en)	2020-03-30
IL215777A0 (en)	2012-01-31
MX2011011190A (en)	2012-02-13
CN102427815A (en)	2012-04-25
JP6179844B2 (en)	2017-08-16

Publication	Publication Date	Title
PL2482859T3 (en)	2016-11-30	Sterilization method
HU0900819D0 (en)	2010-07-28	Lung tissue culture
PL2391391T3 (en)	2019-05-31	Sterilization method
ZA201107903B (en)	2013-01-30	Methods of treating a pulmonary bacterial infection using fluoro-quinolones
IL217492A0 (en)	2012-02-29	Treatment method
PL2534150T3 (en)	2017-09-29	Methods of treating viral infection
IL206491A0 (en)	2010-12-30	Treatment of produce
DK2473482T3 (en)	2014-05-12	Methods of treating orthomyxoviral infections
PL2424559T3 (en)	2024-07-29	Methods of treating bacterial infections using oritavancin
GB0900599D0 (en)	2009-02-18	Treatment
ZA201204249B (en)	2013-02-27	Treatment of microbial infections
PL2281457T3 (en)	2013-03-29	Method for physical treatment of plants
GB0908101D0 (en)	2009-06-24	Treatment of stress
GB0901411D0 (en)	2009-03-11	Treatment
IL218120A0 (en)	2012-04-30	Sterilization method
EP2424539A4 (en)	2012-09-19	Method of treatment of depression
GB0807781D0 (en)	2008-06-04	Treatment of bacterial infection
HU0900278D0 (en)	2009-06-29	Lung tissue culture
GB0918850D0 (en)	2009-12-09	Shellfish treatment
GB0904164D0 (en)	2009-04-22	Method of treatment
GB0921823D0 (en)	2010-01-27	Method of treatment
GB0909807D0 (en)	2009-07-22	Method of treatment
GB0908964D0 (en)	2009-07-01	Treatment of pathogenic infection
GB0907561D0 (en)	2009-06-10	Magnetic treatment
GB0914373D0 (en)	2009-09-30	Treatment method